The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 2.6M data for 1.1M Compounds and 8.9K Targets. Of those, 1,193K data for 550K Compounds and 4.4K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

Advanced Search

10 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
 
Synthesis and structure-activity relationships of potent retinoid X receptor ligandsEBI
TBA
Design, synthesis and structure-activity relationship of novel RXR-selective modulators.EBI
Ligand Pharmaceuticals Inc
Retinoic acid receptor ligands based on the 6-cyclopropyl-2,4-hexadienoic acid.EBI
Ligand Pharmaceuticals Inc
Heteroarotinoids inhibit head and neck cancer cell lines in vitro and in vivo through both RAR and RXR retinoic acid receptors.EBI
University of Oklahoma Health Sciences Center
Synthesis, structure-activity relationships, and RARgamma-ligand interactions of nitrogen heteroarotinoids.EBI
University of Oklahoma Health Sciences Center
Conformationally defined retinoic acid analogues. 4. Potential new agents for acute promyelocytic and juvenile myelomonocytic leukemias.EBI
University of Alabama at Birmingham
Synthesis and structure-activity relationships of retinoid X receptor selective diaryl sulfide analogs of retinoic acid.EBI
Allergan Inc
Synthesis and structure-activity relationships of novel retinoid X receptor-selective retinoids.EBI
Ligand Pharmaceuticals Inc
Design and synthesis of potent retinoid X receptor selective ligands that induce apoptosis in leukemia cells.EBI
Ligand Pharmaceuticals Inc
Conformationally defined 6-s-trans-retinoic acid analogs. 2. Selective agonists for nuclear receptor binding and transcriptional activity.EBI
University of Alabama at Birmingham